New hope to boost blood cells for cancer patients in radiation therapy
NCT ID NCT07128576
Summary
This study aims to see if a drug called romiplostim N01 is safe and effective at raising platelet counts in adults with solid tumors. It focuses on patients whose low platelet counts are caused by treatment regimens that include radiation therapy. The goal is to help manage this side effect so patients can better tolerate their cancer treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.